Mariner, LLC Cerus Corp Transaction History
Mariner, LLC
- $55.8 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CERS
# of Institutions
157Shares Held
148MCall Options Held
84.2KPut Options Held
55.5K-
Baker Bros. Advisors LP New York, NY19.5MShares$35.3 Million0.36% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl18.2MShares$33 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$25.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$19.6 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.54MShares$15.5 Million0.01% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $321M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...